Authors: Dua e Fathah, Areeba Yousaf and Mirza Imran Shahzad
DOI: http://dx.doi.org/10.71081/cvj/2023.001
Abstract
Initially, COVID- 19 occurs in 2019 in the city of Wuhan China and began
to spread. The common indications of COVID-19 are dyspnea, sore throat,
cough, and fatigue. Many drugs have been used to decrease the
overwhelming results such as Ivermectin, Colchicine, Metformin, and
Fluvoxamine are the most affected anti-parasite. Anti-parasitic drugs also
contain some side effects. Numerous dietary factors have been used but
deficiency of vitamin D has been allied with an intensification in ICU
treatment of patients infected with COVID-19. The central role of vitamin D
in the human body is to sustain immunomodulatory, and calcium
homeostasis and have anti-inflammatory, anti-fibrotic properties. Past
studies show that vitamin D has a role in the reduction of respiratory
diseases in adults and children. The common sources of vitamin D are meat,
fish, milk products, eggs, mushrooms, sunlight, etc. Corona-viruses are
enveloped by membranes, contain positive Single-Stranded RNA (+ssRNA),
or can cause infection in equally animals and humans. S protein in the
COVID- 19 binds to the ACE 2 receptor, leading to the virus's entry into the
body. A host with a sufficient level of vitamin D has been allied with
amplified excretion of anti-microbial peptides or depressing the menace
of hypercytokinemia, also tangled in the stimulation of macrophages i.e.,
defensive cells or protected response of Th2 cells. Various studies have
determined that there is no protagonist of vitamin D in managing of hazards
of COVID-19. Thus, this review aims to clarify the immune-modulatory
effects of vitamin D in the control of COVID-19.
Keywords: COVID- 19, Calciferol, Vitamin D, Autoimmune diseases, Metabolism